Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2011
Total Assets: $2.20B
Liabilities Breakdown FY2011
Total Liabilities: $1.24B
Asset Breakdown
Total Assets: $2.20B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $475.3M | 21.6% |
| Accounts Receivable | $183.1M | 8.3% |
| Inventory | $112.4M | 5.1% |
| Property, Plant & Equipment | $133.2M | 6.0% |
| Goodwill | $31.0M | 1.4% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.27B | 57.6% |
Liabilities Breakdown
Total Liabilities: $1.24B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $74.6M | 6.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.16B | 94.0% |